A meta-analysis shows that Immunosuppression permits uncontrolled replication of oncogenic HPV subtypes (e.g., HPV16/18), which disrupt tumor suppressor pathways (p53/Rb) via E6/E7 proteins. Here, TP53 is linked to neoplasm.